title: Source Precision Medicine RT-PCR assay
status: Public on Feb 15 2017
contact.city: Cambridge
contact.first: Karl
contact.middle: George
contact.last: Wassmann
contact.email: karl.wassmann@checkpointsciences.com
contact.state: MA
contact.address: 245 First Street Suite 1800-109
contact.country: USA
contact.institute: CheckPoint Sciences Inc.
contact.phone: 774-893-4313
organism: Homo sapiens
description: PCR assay
  Panel of 169 genes associated with inflammation, immunity, the CTLA4 pathway, oncogenes, and melanoma-specific genes used for exploratory purposes
manufacture_protocol: see published patent application US20110070582 A1 titled Gene Expression Profiling for Predicting the Response to Immunotherapy and/or the Survivability of Melanoma Subjects
  exploratory PCR Assay not commercially available